Article
Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial.
BMC women's health - 24 Aug 2011
Visser Annemiek, Prins Judith B, Hoogerbrugge Nicoline, van Laarhoven Hanneke W M
Abstract excerpt
BACKGROUND: BRCA mutation carriers have a 40-80% life-time risk of developing breast cancer. They may opt for yearly breast cancer surveillance or for prophylactic mastectomy. Both options show increased survival rates. It is a complex choice to be made between these two options. As a result most women experience high levels of distress and high needs for information. To fulfill the needs for psychosocial support...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
